Page last updated: 2024-10-20

uracil and Carotid Artery Diseases

uracil has been researched along with Carotid Artery Diseases in 1 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research Excerpts

ExcerptRelevanceReference
" The current study investigated the effects of alogliptin, a DPP-4 inhibitor, on the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM)."9.22Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). ( Gosho, M; Jinnouchi, H; Kaneto, H; Katakami, N; Kosugi, K; Kuribayashi, N; Mita, T; Onuma, T; Osonoi, T; Shimomura, I; Shiraiwa, T; Umayahara, Y; Watada, H; Yamamoto, T; Yokoyama, H; Yoshii, H, 2016)
" The current study investigated the effects of alogliptin, a DPP-4 inhibitor, on the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM)."5.22Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). ( Gosho, M; Jinnouchi, H; Kaneto, H; Katakami, N; Kosugi, K; Kuribayashi, N; Mita, T; Onuma, T; Osonoi, T; Shimomura, I; Shiraiwa, T; Umayahara, Y; Watada, H; Yamamoto, T; Yokoyama, H; Yoshii, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mita, T1
Katakami, N1
Yoshii, H1
Onuma, T1
Kaneto, H1
Osonoi, T1
Shiraiwa, T1
Kosugi, K1
Umayahara, Y1
Yamamoto, T1
Yokoyama, H1
Kuribayashi, N1
Jinnouchi, H1
Gosho, M1
Shimomura, I1
Watada, H1

Trials

1 trial available for uracil and Carotid Artery Diseases

ArticleYear
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
    Diabetes care, 2016, Volume: 39, Issue:1

    Topics: Aged; Atherosclerosis; Blood Glucose; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Medi

2016